JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 18 April 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.02581-06v1
81/13/7011    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kochs, G.
Right arrow Articles by Martínez-Sobrido, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kochs, G.
Right arrow Articles by Martínez-Sobrido, L.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.02581-06
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Multiple anti-interferon actions of the Influenza A virus NS1 protein

Georg Kochs*, Adolfo García-Sastre, and Luis Martínez-Sobrido*

Department of Virology, University of Freiburg, D-79008 Freiburg, Germany; Department of Microbiology, and Emerging Pathogens Institute, Mount Sinai School of Medicine, New York, NY10029, USA

* To whom correspondence should be addressed. Email: georg.kochs{at}uniklinik-freiburg.de. Luis.Martinez{at}mssm.edu.


   Abstract

Replication and pathogenicity of Influenza A virus (FLUAV) are in part controlled by the interferon (IFN{alpha}/{beta}) system. This virus-host interplay is dependent on the production of IFN{alpha}/{beta} and on the capacity of the viral non-structural protein NS1 to counteract the IFN system. Two different mechanisms have been described for NS1: Blocking the activation of the IFN regulatory factor-3, IRF3, and a block of post-transcriptional processing of cellular mRNAs. Here, we directly compared the ability of NS1 gene products from three different human FLUAV (H1N1) strains to counteract the antiviral host response. We found that A/PR/8/34-NS1 has a strong capacity to inhibit IRF3 and activation of the IFN{beta} promoter, but was unable to suppress expression of other cellular genes. By contrast, NS1 proteins of A/Tx/36/91 and of A/BM/1/18, the virus that caused the Spanish influenza pandemic, caused suppression of additional cellular gene expression. Thus, these NS1 proteins prevented the establishment of an IFN-induced antiviral state, allowing virus replication even in the presence of IFN. Interestingly, the block in gene expression was dependent on a newly described NS1 domain that is important for interaction with the CPSF component of the cellular pre-mRNA processing machinery but is not functional in A/PR/8/34-NS1. We identified Phe-103 and Met-106 residues in NS1 as being critical for CPSF binding together with the previously described C-terminal binding domain. Our results demonstrate the capacity of FLUAV-NS1 to suppress the antiviral host defense at multiple levels, and the existence of strain specific differences that may modulate virus pathogenicity.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.